Serum anticholinergicity is associated with reduced prefrontal brain function in early course schizophrenia.

Schreiber, Sarah R; Wojtalik, Jessica A; Walker, Christopher P; Cho, Raymond Y; Eack, Shaun M; Keshavan, Matcheri S

Schreiber, Sarah R; Wojtalik, Jessica A; Walker, Christopher P; Cho, Raymond Y; Eack, Shaun M; Keshavan, Matcheri S.

Afiliação

Schreiber SR; Geisinger Commonwealth School of Medicine, Scranton, PA, USA.
Wojtalik JA; School of Social Work, University of Pittsburgh, Pittsburgh, PA, USA.
Walker CP; Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
Cho RY; Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA.
Eack SM; School of Social Work, University of Pittsburgh, Pittsburgh, PA, USA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Keshavan MS; Department of Psychiatry, Mental Health Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 75 Fenwood Rd, Boston, MA 02115, USA. Electronic address: mkeshava@bidmc.harvard.edu.

Psychiatry Res Neuroimaging ; 281: 31-34, 2018 11 30.

Article em En | MEDLINE | ID: mdl-30216862

Assuntos

Antagonistas Colinérgicos/sangue; Esquizofrenia/sangue; Adulto; Antagonistas Colinérgicos/efeitos adversos; Cognição/efeitos dos fármacos; Feminino; Humanos; Masculino; Córtex Pré-Frontal/efeitos dos fármacos; Córtex Pré-Frontal/fisiopatologia; Esquizofrenia/tratamento farmacológico; Esquizofrenia/fisiopatologia; Adulto Jovem

Palavras-chave

Anticholinergic activity; Prefrontal brain function; Schizophrenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antagonistas Colinérgicos Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google